Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.

Authors :: Rajab F
Mujahid A
Naseer B
Source :: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 May 04; Vol. 10 (3), pp. 263-264.
Publication Year :: 2024

Subjects :: Humans
Treatment Outcome
Anticoagulants adverse effects
Anticoagulants therapeutic use
Anticoagulants administration & dosage
Coronary Artery Disease mortality
Coronary Artery Disease therapy
Coronary Artery Disease diagnosis
Hirudins adverse effects
Hirudins administration & dosage
Percutaneous Coronary Intervention adverse effects
Percutaneous Coronary Intervention mortality
Diabetes Mellitus, Type 2 drug therapy
Diabetes Mellitus, Type 2 diagnosis
Diabetes Mellitus, Type 2 blood
Heparin adverse effects
Heparin therapeutic use
Heparin administration & dosage
Peptide Fragments therapeutic use
Peptide Fragments adverse effects
Antithrombins adverse effects
Antithrombins therapeutic use
Antithrombins administration & dosage
Recombinant Proteins therapeutic use
Recombinant Proteins adverse effects
Recombinant Proteins administration & dosage

Full Text Access

Tools